DrugDashboards

Market view

lidocaine 4% phenylephrine hcl 0.25% hemorrhoid · Cream

4 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

What changed in the last 90 days

Every detected change for lidocaine 4% phenylephrine hcl 0.25% hemorrhoid, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr exited
    Jiangxi Yudexi Pharmaceutical Co., LTD · lidocaine 4% phenylephrine hcl 0.25% hemorrhoid
  • Mfr entered
    Jiangxi Yudexi Pharmaceutical Co., LTD · lidocaine 4% phenylephrine hcl 0.25% hemorrhoid
  • Mfr entered
    Jiangxi Yudexi Pharmaceutical Co., LTD · lidocaine 4% phenylephrine hcl 0.25% hemorrhoid

Same drug class

Other molecules FDA puts in alpha-1 Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Lidocaine 4% phenylephrine hcl 0.25% hemorrhoid in shortage right now?
No. FDA does not currently list Lidocaine 4% phenylephrine hcl 0.25% hemorrhoid in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Lidocaine 4% phenylephrine hcl 0.25% hemorrhoid?
1 company has marketed Lidocaine 4% phenylephrine hcl 0.25% hemorrhoid in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.